Ascendis Pharma (NASDAQ:ASND) Upgraded to “Strong-Buy” by ValuEngine

Retrieved on: 2018-05-17 19:37:30

Tags for this article:

Click the tags to see associated articles and topics

Ascendis Pharma (NASDAQ:ASND) Upgraded to “Strong-Buy” by ValuEngine. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new stake in Ascendis Pharma during the first quarter worth approximately $162,160,000. venBio Select Advisor ...</div>

Article found on:

View Original Article